Interleukin-2 gene-modified allogeneic tumor cells for treatment of relapsed neuroblastoma.
Bowman LC, Grossmann M, Rill D, Brown M, Zhong WY, Alexander B, Leimig T, Coustan-Smith E, Campana D, Jenkins J, Woods D, Brenner M.
Bowman LC, et al. Among authors: leimig t.
Hum Gene Ther. 1998 Jun 10;9(9):1303-11. doi: 10.1089/hum.1998.9.9-1303.
Hum Gene Ther. 1998.
PMID: 9650615